Clinical Study
Long-Term Efficacy of Postpartum Intravenous Iron Therapy
Table 2
Laboratory data 6 months post-partum.
| Characteristics | Oral iron | Intravenous + oral iron | | ( = 150) | ( = 75) |
| Hb (g/dL) | 13.3 (0.8)10.9–15.3 | 13.3 (0.8)11.1–15.7 | 0.68 | Haematocrit (%) | 39.5 (2.3)32.8–46.4 | 39.4 (2.6)34.1–47.6 | 0.78 | MCV (fL) | 85.6 (4.4)71.7–97.8 | 86.6 (5.1)72.7–97.7 | 0.13 | MCH (pg) | 28.8 (1.7)22.5–32.1 | 29.3 (1.9)21.8–34 | 0.047 | MCHC (g/dL) | 33.6 (1.0)30.4–35.9 | 33.8 (1.1)30.0–37.3 | 0.15 | Microcytes (%) | 1.5 (1.9)0.1–13.2 | 1.3 (2.1)0.1–13.9 | 0.48 | Hypochromic erythrocytes (%) | 1.7 (3.6)0.1–24.9 | 1.3 (3.0)0.1–18.9 | 0.43 | Ferritin (g/L) | 32.9 (20.1)4–111 | 57.7 (49.3)9–296 | <0.0001 | CRP (mg/L) | 2.0 (4.4)0–39 | 1.8 (2.7)0–11 | 0.69 |
|
|
Values are expressed as mean (SD) range.
|